After clinical trial hold and plunging stock, what's next for Juno Therapeutics? | KUOW News and Information

After clinical trial hold and plunging stock, what's next for Juno Therapeutics?

Jul 11, 2016

Bill Radke speaks with Luke Timmerman about what went wrong during Seattle-based Juno Therapeutics' clinical trial of an immunotherapy treatment for leukemia and what it might mean for the company.